Dong Joon Kim

Dankook University

H指数:28

被引数:2,596

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Dual Roles of hABCB1 in Drug Resistance and Immune Evasion: Implications for Lung Cancer Therapy

hABCB1在药物抵抗和免疫逃逸中的双重作用：对肺癌治疗的启示

ACS Omega

IF4.3

2026-05-110

The multifaceted metabolite landscape of gut microbiota: systems pharmacology insights into Crohn’s disease, irritable bowel disease, and ulcerative colitis

肠道微生物组的多样化代谢物景观：系统药理学对克罗恩病、肠易激综合征和溃疡性结肠炎的见解

Molecular Diversity

IF3.8

2026-01-090

PRE

From Orange to Oncology: Anti-Inflammatory and Anti-Cancer Mechanisms of Sinensetin

从橙子到肿瘤学：Sinensetin的抗炎和抗癌机制

Cells

IF5.2

2026-01-090

OAAI

Clinical-data-driven pharmacological framework in liver disease: From liver cirrhosis to hepatocellular carcinoma

临床数据驱动的肝脏疾病药理学框架：从肝硬化到肝细胞癌

BRITISH JOURNAL OF PHARMACOLOGY

IF7.7

2025-12-010

PRE

The crosstalk between gut microbiota and microbiota-derived metabolites in hepatocellular carcinoma

肠道微生物组与微生物衍生代谢物在肝细胞癌中的串扰

Critical Reviews in Microbiology

IF5.1

2025-06-040

PRE

Therapeutic implication of oxidative stress-induced growth inhibitor 1 (OSGIN1) in cancer

氧化应激诱导的生长抑制剂1（OSGIN1）在癌症中的治疗意义

ONCOGENE

IF7.3

2025-03-170

PRE

OSGIN1 is a novel TUBB3 regulator that promotes tumor progression and gefitinib resistance in non-small cell lung cancer

OSGIN1是一种新型的TUBB3调节剂，可促进非小细胞肺癌的肿瘤进展和吉非替尼耐药

CELLULAR AND MOLECULAR LIFE SCIENCES

IF6.2

2023-08-306

Hippocalcin-like 1 is a key regulator of LDHA activation that promotes the growth of non-small cell lung carcinoma

CELLULAR ONCOLOGY

IF4.8

2022-01-3111

PRE

Ethyl Ferulate Suppresses Esophageal Squamous Cell Carcinoma Tumor Growth Through Inhibiting the mTOR Signaling Pathway

FRONTIERS IN ONCOLOGY

IF3.3

2022-01-287

OAAI

3,3'-Diindolylmethane plus Eflornithine suppress DNA Replication and Cell Cycle in Esophageal Squamous Cell Carcinoma in vivo

JOURNAL OF CANCER

IF3.2

2022-01-011

OAAI

BRD4 drives esophageal squamous cell carcinoma growth by promoting RCC2 expression

ONCOGENE

IF7.3

2021-11-0820

PRE

Targeting integrin αvβ3 with indomethacin inhibits patient-derived xenograft tumour growth and recurrence in oesophageal squamous cell carcinoma

CLINICAL AND TRANSLATIONAL MEDICINE

IF6.8

2021-10-2821

Harmaline isolated from Peganum harmala suppresses growth of esophageal squamous cell carcinoma through targeting mTOR

从骆驼Peganum harmala分离出的Harmaline通过靶向mTOR抑制食管鳞状细胞癌的生长

PHYTOTHERAPY RESEARCH

IF6.3

2021-09-2016

PRE

Ipriflavone Suppresses Growth of Esophageal Squamous Cell Carcinoma Through Inhibiting mTOR In Vitro and In Vivo

FRONTIERS IN ONCOLOGY

IF3.3

2021-06-104

OAAI

EPRS/GluRS promotes gastric cancer development via WNT/GSK-3β/β-catenin signaling pathway

GASTRIC CANCER

IF5.1

2021-03-1928

OAAI

2,6-DMBQ suppresses cell proliferation and migration via inhibiting mTOR/AKT and p38 MAPK signaling pathways in NSCLC cells

2，6-DMBQ通过抑制mTOR/AKT和p38 MAPK信号通路抑制NSCLC细胞增殖和迁移

JOURNAL OF PHARMACOLOGICAL SCIENCES

IF2.9

2021-03-015

OAAI

Heterogeneity Analysis of Esophageal Squamous Cell Carcinoma in Cell Lines, Tumor Tissues and Patient-Derived Xenografts

JOURNAL OF CANCER

IF3.2

2021-01-0114

OAAI

2,6-DMBQ is a novel mTOR inhibitor that reduces gastric cancer growth in vitro and in vivo

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

IF12.8

2020-06-0913

OAAI

Lapachol is a novel ribosomal protein S6 kinase 2 inhibitor that suppresses growth and induces intrinsic apoptosis in esophageal squamous cell carcinoma cells

PHYTOTHERAPY RESEARCH

IF6.3

2019-06-2114

PREAI

Purpurogallin is a novel mitogen-activated protein kinase kinase 1/2 inhibitor that suppresses esophageal squamous cell carcinoma growth in vitro and in vivo

Purpurogallin是一种新型的丝裂原活化蛋白激酶激酶1/2抑制剂，可在体外和体内抑制食管鳞状细胞癌的生长。

MOLECULAR CARCINOGENESIS

IF3.2

2019-05-1725

PREAI

Dong Joon Kim

个人简介

教育背景

工作经历

荣誉奖项

研究方向